| Moral distress amongst American physician trainees regarding futile treatments at the end of life: a qualitative study E Dzeng, A Colaianni, M Roland, D Levine, MP Kelly, S Barclay, TJ Smith Journal of general internal medicine 31, 93-99, 2016 | 160 | 2016 |
| Influence of institutional culture and policies on do-not-resuscitate decision making at the end of life E Dzeng, A Colaianni, M Roland, G Chander, TJ Smith, MP Kelly, ... JAMA internal medicine 175 (5), 812-819, 2015 | 116 | 2015 |
| A long shadow: Nazi doctors, moral vulnerability and contemporary medical culture A Colaianni Journal of Medical Ethics 38 (7), 435-438, 2012 | 57 | 2012 |
| Injuries caused by explosion of electronic cigarette devices CA Colaianni, LF Tapias, R Cauley, R Sheridan, JT Schulz, J Goverman Eplasty 16, 2016 | 54 | 2016 |
| Columbia university's axel patents: Technology transfer and implications for the bayh‐dole act A Colaianni, R COOK‐DEEGAN The Milbank Quarterly 87 (3), 683-715, 2009 | 53 | 2009 |
| Lessons from the commercialization of the Cohen-Boyer patents MP Feldman, A Colaianni, CK Liu Intellectual Property Management in Health and Agricultural Innovation: A …, 2007 | 50 | 2007 |
| Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease A Colaianni, S Chandrasekharan, R Cook-Deegan Genetics in Medicine 12, S5-S14, 2010 | 49 | 2010 |
| Lessons from the commercialization of the Cohen-Boyer patents: the Stanford University licensing program. MP Feldman, A Colaianni, KC Liu Kang [Liu | 46 | 2007 |
| Homing in on the social: system-level influences on overly aggressive treatments at the end of life E Dzeng, D Dohan, JR Curtis, TJ Smith, A Colaianni, CS Ritchie Journal of pain and symptom management 55 (2), 282-289. e1, 2018 | 39 | 2018 |
| Commercializing Cohen-Boyer 1980-1997 M Feldman, A Colaianni, K Liu Kauffman Foundation, 5-21, 2005 | 37 | 2005 |
| Intellectual property management in health and agricultural innovation: A handbook of best practices MP Feldman, A Colaianni, K Liu, A Krattiger, R Mahoney, J Thomson, ... MIHR, Oxford 1, 1797-807, 2007 | 13 | 2007 |
| The perils of taking property too far C Heaney, J Carbone, R Gold, T Bubela, CM Holman, A Colaianni, ... Stanford journal of law, science & policy 1, 46, 2009 | 12 | 2009 |
| Chapter D, 17.22: Lessons from the commercialization of the Cohen-Boyer patents MP Feldman, A Colaianni, CK Liu Intellectual Property Management in Health and Agricultural Innovation: A …, 2008 | 6 | 2008 |
| Institutional Culture and Policies’ Influence on Do-Not-Resuscitate Decision-Making at the End of Life E Dzeng, A Colaianni, M Roland, TJ Smith J Am Med Assoc Intern Med, 2015 | 2 | 2015 |
| Lessons from the commercialization of the Cohen-Boyer pa-tents F Maryann, A COLAIANNI, CK Liu Intellectual Property Management in Health and Agricultural Innovation: A …, 2007 | 2 | 2007 |
| The Language of Medicine A Colaianni Annals of Internal Medicine 157 (2), 156-157, 2012 | 1 | 2012 |
| Effect of sarcopenia on survival outcomes in patients with nasopharyngeal and sinonasal cancer. JH Kim, R Mualla, JC Mace, NM Santucci, MJ Hill, H Pfeifer, B Olson, ... International Forum of Allergy & Rhinology 13 (8), 2023 | | 2023 |
| Supplementary Online Content E Dzeng, A Colaianni, M Roland | | 2015 |
| Up for Yes A Colaianni Journal of general internal medicine 29 (11), 1563-1564, 2014 | | 2014 |
| Case Study: The Axel Patents-A Case Study in University-Technology Transfer A Colaianni | | 2013 |
